BII Backs Quantum Chip Diagnostic Startup Diasense With Additional €1.3 Million Investment
Published: 17 Mar 2026
Author: Precedence Research
Danish, a Copenhagen-based quantum start-up, has secured €1.3 million in funding from the BioInnovation Institute (BII)as part of the Venture House 8 cohort. The funding is intended to support product development, operational scaling, and progress toward market deployment across healthtech. Enabling the Copenhagen-based institute to expand into new strategic areas and geographies while supporting a larger number of entrepreneurs and startups across Europe.
The company is industrialising real-time diagnostic and process insights for a quantum diamond magnetic microscope for next-generation semiconductor fabrication. By utilising the quantum properties in diamond, the platform enables contactless chip failure analysis with microscopic resolution and extreme sensitivity. This technical approach allows manufacturers to uncover complex failure mechanisms and electromagnetic anomalies that remain invisible to traditional scanning electron microscopy or classical induction-based probes. The technology is aimed at a growing challenge in the semiconductor industry, identifying failure mechanisms that can occur during fabrication but remain difficult to detect with conventional inspection tools.
According to Toward Healthcare, the Stereo Microscopes market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 976.77 million in 2026 to approximately USD 1488.23 million by 2035, representing a compound annual growth rate (CAGR) of 4.79% from 2026 to 2035. The main purpose is to provide a fast, non-destructive diagnostic layer that can keep pace with the accelerating complexity of sub-5nm chip architectures.
Director of Quantum at BII, Jakob Svagin, explained the continued investment, saying the decision reflects both the strength of Diasense’s technology and the team’s ability to adapt as they move toward commercialisation.
Sustainability Technologies
Synuca Therapeutics: It is the first company funded through the DKK320 million innovation partnership with the Lundbeck Foundation. It develops first-in-class disease-modifying therapy for Parkinson’s disease and brain disorders.
MicroMiner - Advancing recycling technology to improve the sustainability of EV batteries as it transitions from research to deployable solutions.
A recent report by Toward Healthcare highlights that the Stereo Microscopes market is experiencing Diasense will leverage BII’s specialised facilities and strategic network to refine its hardware for the rigorous reliability standards required by tier-one semiconductor.